PPRC1 and ovarian cancer: Secondly, combined with clinical-information data, we speculated that the expression of PPRC1 is negatively correlated with survival outcomes in ovarian cancer (OV) and liver hepatocellular carcinoma (LIHC) in terms of OS, DSS, and PFI.